to main content Joint Commission Enterprise President and Chief Executive Officer Dr. Jonathan B. Perlin named to Modern Healthcare’s 50 Most Influential Clinical Executives | The Joint Commission

Joint Commission Enterprise President and Chief Executive Officer Dr. Jonathan B. Perlin named to Modern Healthcare’s 50 Most Influential Clinical Executives

Wednesday, June 28, 2023

Media Contact:  
Katie Bronk
Corporate Communications  
(630) 792-5175

(OAKBROOK TERRACE, Illinois, June 28, 2023) – The Joint Commission is proud to announce that Jonathan B. Perlin, MD, PhD, MSHA, MACP, FACMI, president and chief executive officer, The Joint Commission enterprise, was recognized by Modern Healthcare as one of the 50 Most Influential Clinical Executives for 2023. 

The program honors clinicians in executive roles who are deemed by their peers and the senior editors of Modern Healthcare as paving the way to better health care through their executive responsibility, leadership qualities, innovation, community services, and achievements inside and outside of their respective organizations. 

“The 50 clinical leaders we’ve recognized started as physicians or nurses, and regardless of their titles today, that strong foundation of caring for patients has benefited their organizations and communities,” says Mary Ellen Podmolik, editor-in-chief of Modern Healthcare. “These executives are broadening access to care through expansion and embracing digital tools to make their operations more efficient and their patients more connected. They also are tackling workforce challenges by developing strategies to attract newcomers to the field. Modern Healthcare’s 50 Most Influential Clinical Executives are helping propel the industry forward.”

Dr. Perlin joined The Joint Commission in March 2022. Under his strategic leadership, The Joint Commission has made significant progress to improve health care equity for all patients, reduce health care’s carbon footprint and leverage learning processes for a more data-driven, evidence-based and outcomes-oriented approach to accreditation and certification.

Over the past year, Dr. Perlin has directed new initiatives to improve patient safety, quality and health care equity. The Joint Commission implemented new requirements to reduce health care disparities, which will be elevated to a National Patient Safety Goal on July 1. Under his direction, The Joint Commission also eliminated 14% of its standards to streamline requirements and make them as impactful as possible. A second tranche of eliminated standards will occur in late August. 

Dr. Perlin has made it a top priority for The Joint Commission to work closely with stakeholders across health care to achieve a shared vision — that all people always experience the safest, highest quality, best-value health care across all settings. 

Dr. Perlin’s distinguished career has spanned the academic, public and private sectors, where he has led groundbreaking improvements in health care quality, safety and the use of information technology. Previously, he was president, Clinical Operations, and chief medical officer at HCA Healthcare, Nashville. He also served as Under Secretary for Health in the U.S. Department of Veterans Affairs. Additionally, he serves on numerous boards and maintains faculty appointments at Vanderbilt University, Nashville, and Virginia Commonwealth University, Richmond, Virginia. 

Learn more about the 50 Most Influential Clinical Executives program. 


About The Joint Commission  
Founded in 1951, The Joint Commission seeks to continuously improve healthcare for the public, in collaboration with other stakeholders, by evaluating healthcare organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission accredits and certifies more than 22,000 healthcare organizations and programs in the United States. An independent, nonprofit organization, The Joint Commission is the nation’s oldest and largest standards-setting and accrediting body in healthcare. Learn more about The Joint Commission at